Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 3 | MIG | 17.5 | 46 | |
RA2159 | Sigma A6730 | 3.0 | uM | 3 | MIG | 19.0 | 76 | ||||
N2586 | IL-6 | 100 | ug/mL | 3 | MIG | 63.5 | 62 | ||||
N2586 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 3 | MIG | 57.0 | 46 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | MIG | 38.0 | 52 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | MIG | 53.5 | 58 | |
N2586 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | MIG | 35.0 | 59 | |
N2586 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 3 | MIG | 36.0 | 61 | |
N2586 | Sigma A6730 | 3.0 | uM | 3 | MIG | 47.0 | 63 | ||||
RA2159 | IL-1 alpha | 100 | ng/mL | 3 | MIG | 42.5 | 72 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 3 | MIG | 47.0 | 50 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | MIG | 53.0 | 81 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | MIG | 53.0 | 51 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | MIG | 42.0 | 56 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | MIG | 24.0 | 57 | |
RA2159 | PI103 | 0.1 | uM | 3 | MIG | 17.0 | 80 | ||||
N2586 | IL-1 alpha | 100 | ng/mL | 3 | MIG | 128.0 | 54 | ||||
N2586 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 3 | MIG | 215.0 | 53 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | MIG | 162.0 | 57 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | MIG | 206.0 | 65 | |
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | MIG | 47.0 | 54 | |
N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | MIG | 68.0 | 71 | |
N2586 | PI103 | 0.1 | uM | 3 | MIG | 40.0 | 62 | ||||
0 | MIG | 12.0 | 58 | ||||||||
RA2159 | TNF-a | 100 | ng/mL | 3 | MIG | 73.5 | 64 |